Table 1. Clinical baseline data and score grouping of 53 patients with OSs in GES21257 dataset.
Clinical features | Cases, n (%) | High 3-GRM score group, n (%) | Low 3-GRM score group, n (%) | P* |
Patients(n) | 53 | 28 | 25 | |
Median age(range) | 17 (14-19) | 16.5(14-19) | 17(13-19) | 0.71 |
Gender | ||||
Female | 19 (35.8) | 7 (25.0) | 12 (48.0) | 0.08 |
Male | 34 (64.2) | 21 (75.0) | 13 (52.0) | |
Histological Subtype | ||||
Osteoblastic | 32 (60.4) | 19 (67.9) | 13 (52.0) | 0.24 |
Others | 21 (39.6) | 9 (32.1) | 12 (48.0) | |
Tumor location | ||||
Lower limb | 44 (83.0) | 23 (82.1) | 21 (87.5) | 0.88 |
upper limb | 8 (15.1) | 5 (17.9) | 3 (12.5) | |
Unknow | 1(1.89) | - | - | |
Huvos grade | ||||
I-II | 29 (54.7) | 14 (58.3) | 15 (65.2) | 0.85 |
III-IV | 18 (34.0) | 10 (41.7) | 8 (34.8) | |
Unknow | 6(11.3) | - | - | |
Metastases at diagnosis | ||||
No | 39 (73.6) | 20 (71.4) | 19 (76.0) | 0.95 |
Yes | 14 (26.4) | 8 (28.6) | 6 (24.0) |
*Comparison of high 3-GRM score group and low 3-GRM score group.